老年人糖尿病伴衰弱的干预研究进展

doi:10.3969/j.issn.1003-9198.2021.05.023

[1] FRIED L P, TANGEN C M, WALSTON J, et al. Frailty in older adults: evidence for a phenotype[J]. J Gerontol A Biol Sci Med Sci, 2001, 56(3):M146-M157.
[2] GARCÍA-ESQUINAS E, GRACIANI A, GUALLAR-CASTILLÓN P, et al. Diabetes and risk of frailty and its potential mechanisms: a prospective cohort study of older adults[J]. J Am Med Dir Assoc, 2015, 16(9):748-754.
[3] SAUM K, DIETZENBACH A K, MÜLLER H, et al. Frailty prevalence and 10-year survival in community-dwelling older adults: results from the ESTHER cohort study[J]. Eur J Epidemiol, 2014, 29(3):171-179.
[4] JUNG H, KIM S, AHN S, et al. Prevalence and outcomes of frailty in Korean elderly population: comparisons of a multidimensional frailty index with two phenotype models[J]. PLoS One, 2014, 9(2):e87958.
[5] LI C L, STANAWAY F F, LIN J D, et al. Frailty and health care use among community-dwelling older adults with diabetes: a population-based study[J]. Clin Interv Aging, 2018, 13:2295-2300.
[6] CHHETRI J K, ZHENG Z, XU X, et al. The prevalence and incidence of frailty in pre-diabetic and diabetic community-dwelling older population: results from Beijing longitudinal study of aging II (BLSA-II)[J]. Bmc Geriatr, 2017, 17(1):47-54.
[7] ULLEY J, ABDELHAFIZ A H. Frailty predicts adverse outcomes in older people with diabetes[J]. Practitioner, 2017, 261(1800): 17-20.
[8] MA L. Current situation of frailty screening tools for older adults[J]. J Nutr Health Aging, 2019, 23(1):111-118.
[9] LEROITH D, BIESSELS G J, BRAITHWAITE S S, et al. Treatment of diabetes in older adults: an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 2019, 104(5):1520-1574.
[10]MORLEY J E, MALMSTROM T K, RODRIGUEZ-MAÑAS L, et al. Frailty, sarcopenia and diabetes[J]. J Am Med Dir Assoc, 2014, 15(12):853-859.
[11]GARCIA D E, ALONSO R J, HERRERA F N, et al. Effect of strength exercise with elastic bands and aerobic exercise in the treatment of frailty of the elderly patient with type 2 diabetes mellitus[J]. Endocrinol Diabetes Nutr, 2019, 66(9):563-570.
[12]THEOU O, STATHOKOSTAS L, ROLAND K P, et al. The effectiveness of exercise interventions for the management of frailty: a systematic review[J]. J Aging Res, 2011. DOI: 10.4061/2011/569194.
[13]FRANKEL J E, BEAN J F, FRONTERA W R. Exercise in the elderly: research and clinical practice[J]. Clin Geriatr Med, 2006, 22(2):239-256.
[14]SINCLAIR A J, ABDELHAFIZ A, DUNNING T, et al. An international position statement on the management of frailty in diabetes mellitus: Summary of Recommendations 2017[J]. J Frailty Aging, 2018, 7(1):10-20.
[15]中国老年医学学会老年内分泌代谢分会,解放军总医院国家老年疾病临床医学研究中心,中国老年糖尿病诊疗措施专家共识编写组. 中国老年2型糖尿病诊疗措施专家共识(2018年版)[J]. 中华内科杂志, 2018, 57(9):626-641.
[16]ABDELHAFIZ A H, SINCLAIR A J. Diabetes, nutrition, and exercise[J]. Clin Geriatr Med, 2015, 31(3):439-451.
[17]American Diabetes Association. 5. Facilitating behavior change and well-being to improve health outcomes: Standards of Medical Care in Diabetes—2020[J]. Diabetes Care 2020, 43(Suppl 1): S48-S65.
[18]IMRAN S A, AGARWAL G, BAJAJ H S, et al. Targets for glycemic control[J]. Can J Diabetes, 2018, 42: S42-S46.
[19]HUANG C, WENG S, TSAI K, et al. Long-term mortality risk after hyperglycemic crisis episodes in geriatric patients with diabetes: a national population-based cohort study[J]. Diabetes Care, 2015, 38(5):746-751.
[20]YANAGITA I, FUJIHARA Y, EDA T, et al. Low glycated hemoglobin level is associated with severity of frailty in Japanese elderly diabetes patients[J]. J Diabetes Invest, 2018, 9(2):419-425.
[21]American Diabetes Association. 12. Older adults: Standards of medical care in diabetes—2020[J]. Diabetes Care, 2020, 43(Suppl 1): S152-S162.
[22]COSENTINO F, GRANT P J, ABOYANS V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD[J]. Eur Heart J, 2020, 41(2):255-323.
[23]International Diabetes Federation. New IDF clinical practice recommendations for managing type 2 diabetes in primary care[J]. Diabetes Res Clin Pract, 2017, 132: 169-170.
[24]中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中华糖尿病杂志, 2018, 38(4):292-344.
[25]FRANCHIN A, MARAN A, BRUTTOMESSO D, et al. The GesTIO protocol experience: safety of a standardized order set for subcutaneous insulin regimen in elderly hospitalized patients[J]. Aging Clin Exp Res, 2017, 29(6):1087-1093.
[26]KHOSLA S, FARR J N, TCHKONIA T, et al. The role of cellular senescence in ageing and endocrine disease[J]. Nat Rev Endocrinol, 2020, 16(5):263-275.
[27]HICKSON L J, LANGHI PRATA L G P, BOBART S A, et al. Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease[J]. EBioMedicine, 2019, 47:446-456.
[28]SASAKI T. Sarcopenia, frailty circle and treatment with sodium-glucose cotransporter 2 inhibitors[J]. J Diabetes Invest, 2019, 10(2):193-195.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Recommended 10

[1]	WANG Su, ZHAO Yijing, WEI Chenmin, CHEN Kun, CAO Wen, WANG Kun, YANG Yu. Correlation of triglyceride-glucose index with low-density lipoprotein subtypes in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2024, 38(10): 1002-1006.
[2]	GU Chonghuai, XIANG Xuejun, ZHENG Yuanxi, QIAO Rui, LIN Song. Efficacy of dapagliflozin in elderly patients undergoing coronary intervention with type 2 diabetes mellitus and ejection fraction reduced heart failure [J]. Practical Geriatrics, 2024, 38(10): 1025-1029.
[3]	. [J]. Practical Geriatrics, 2024, 38(10): 1066-1069.
[4]	LIU Qianhui, YAO Zijun, HE Yuli, XU Yunfan, WU Jun. Effects of HbA1c level on cardiac structure and function in elderly patients with type 2 diabetes mellitus and chronic heart failure [J]. Practical Geriatrics, 2024, 38(5): 491-437.
[5]	LIU Tongjun, ZHAO Yajie, HU Jieling, HU Yang, LIANG Wei. Effect of glucose metabolic disorders on serum levels of activin-A [J]. Practical Geriatrics, 2024, 38(5): 495-437.
[6]	. [J]. Practical Geriatrics, 2024, 38(5): 521-437.
[7]	. [J]. Practical Geriatrics, 2024, 38(5): 529-437.
[8]	TANG Yuan, DENG Shufang, HE Yongmei, DAI Yuxuan, LUO Jing. The status of health literacy and correlation with frailty in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2024, 38(3): 255-259.
[9]	DAI Ling-li, YU Yun. Association of estimated glomerular filtration rate with insulin resistance and β-cell function in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2023, 37(12): 1219-1223.
[10]	FAN Ting-yong, YUAN Li, YANG Xiao-ling, CHEN Qian. Assessment effect of Caprini scale on venous thromboembolism in elderly patients with diabetes [J]. Practical Geriatrics, 2023, 37(12): 1233-1237.
[11]	ZHANG He-cheng, WEI Su. Correlation of serum ferritin level with diabetic foot in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2023, 37(11): 1111-1114.
[12]	HU Yan, WU Hai-di, WANG Xue-fei, LOU Qing-lin, YE Qing, GU Liu-bao, DAI Jing, SONG Xiao-bo. Correlation between diabetic foot risk score and urinary microalbumin/creatinine ratio in elderly patients with type 2 diabetes [J]. Practical Geriatrics, 2023, 37(11): 1134-1137.
[13]	. [J]. Practical Geriatrics, 2023, 37(11): 1170-1175.
[14]	ZHANG Lin-ying, MEI Qun-chao, ZHANG Wei-qi, HU Yi-lan. Application of resistance training combined with high milk protein nutrition in elderly patients with type 2 diabetes mellitus and sarcopenia [J]. Practical Geriatrics, 2023, 37(10): 995-999.
[15]	. [J]. Practical Geriatrics, 2023, 37(10): 1064-1068.